The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA has said that Bayer’s Trasylol increases the risk of death compared to similar drugs. Trasylol also known as aprotinin, is used in heart bypass surgery to stem excessive bleeding. The drug works by blocking enzymes that dissolve blood clots, hence less bleeding. However, the blood clots are a risk factor for heart attacks and death. Curiously, the FDA has stated a month earlier that the drug can remain on the market in spite of these risks.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest